LitAlert ~~

    • Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic.
    • Saghatchian M, Abehsera M, Yamgnane A, Geyl C, Gauthier E, Hélin V, Bazire M, Villoing-Gaudé L, Reyes C, Gentien D, Golmard L, Stoppa-Lyonnet D.
    • Breast Cancer Res Treat. 2022 Jan 7. doi: 10.1007/s10549-021-06445-8. Epub ahead of print.
    • Identification of CHEK2 germline mutations in BRCA1/2 and PALB2 negative breast and ovarian cancer patients.
    • Aksoy F, Tezcan Unlu H, Cecener G, Guney Eskiler G, Egeli U, Tunca B, Efendi Erdem E, Senol K, Gokgoz MS.
    • Hum Hered. 2022 Jan 6. doi: 10.1159/000521369. Epub ahead of print.
    • A Survey of the Awareness and Educational Needs of Nurses in Nagasaki Prefecture Regarding Hereditary Breast and Ovarian Cancer.
    • Matsumoto M, Sasaki N, Tsukigawa Y, Otsubo R, Yano H, Nagayasu T.
    • J Cancer Educ. 2022 Jan 6. doi: 10.1007/s13187-022-02132-4. Epub ahead of print.
    • Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observation.
    • Pitiyarachchi O, Phillips KA, Friedlander M.
    • Cancer Treat Res Commun. 2022 Jan 1;30:100504. doi: 10.1016/j.ctarc.2021.100504. Epub ahead of print.
    • Non-BRCA Early-Onset Breast Cancer in Young Women.
    • Gao Y, Samreen N, Heller SL.
    • Radiographics. 2022 Jan-Feb;42(1):5-22. doi: 10.1148/rg.210109.
    • Review